Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy, Safety and Pharmacokinetics of 2 Dose Regimens of TP-434 Compared with Ertapenem in Adult Community- Acquired Complicated Intra-abdominal Infections

Next Previous
Search
Trial Profile

A Phase 2, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy, Safety and Pharmacokinetics of 2 Dose Regimens of TP-434 Compared with Ertapenem in Adult Community- Acquired Complicated Intra-abdominal Infections

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 05 Sep 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Eravacycline (Primary) ; Ertapenem
  • Indications Gram-negative infections; Intra-abdominal infections
  • Focus Therapeutic Use
  • Sponsors Tetraphase Pharmaceuticals

    • Most Recent Events

    • 19 Sep 2018 According to Tetraphase Pharmaceuticals media release, data from this trial will be presented at the Infectious Disease Society of Americas (IDSA) Infectious Disease Week (IDWeek) 2018.
    • 16 Dec 2013 Results published in the Antimicrobial Agents and Chemotherapy.
    • 04 Sep 2013 Results will be presented at Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2013) according to a Trius Therapeutics media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top